home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ:MLTX)

11.95 -1.23 (-9.33%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MoonLake Immunotherapeutics - Class A Ordinary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

MoonLake Immunotherapeutics presents positive 12-week data from the Phase 2 MIRA trial with Nanobody® Sonelokimab for Hidradenitis Suppurativa at the European Academy of Dermatology and Venereology Congress

October 11, 2023

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your Portfolio ↗

September 27, 2023

Dive into these seven strong buy biotech stocks, handpicked by Wall Street, to inject vigor into your investment game.

Via InvestorPlace

The Latest Analyst Ratings for MoonLake ↗

September 18, 2023

Via Benzinga

These 8 Stocks Are Outperforming Nvidia In 2023 ↗

September 18, 2023

Carvana has surged 1,001%, leading huge winners this year.

Via Investor's Business Daily

Expert Ratings for MoonLake ↗

August 31, 2023

Via Benzinga

10 Analysts Have This to Say About MoonLake ↗

August 14, 2023

Via Benzinga

Analyst Expectations for MoonLake's Future ↗

July 26, 2023

Via Benzinga

Where MoonLake Stands With Analysts ↗

July 03, 2023

Via Benzinga

Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 12, 2023

Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock.

Via Benzinga

Why Shares of MoonLake Immunotherapeutics Are Rising Tuesday ↗

September 12, 2023

A competitor's clinical trial stumble may be benefiting MoonLake.

Via The Motley Fool

Casey's General Stores, Cognyte Software, Beauty Health And Other Big Stocks Moving Higher On Tuesday ↗

September 12, 2023

U.S. stocks traded lower, with the Dow Jones gaining around 90 points on Tuesday. Here are some big stocks recording gains in today’s session. Shengfeng Development Limited (NASDAQ: SFWL) shares jumped...

Via Benzinga

Topics Stocks

The Surprising Acelyrin News That Sent Rival MoonLake, A Top 1% Stock, Soaring 19% ↗

September 12, 2023

The companies are both working on treatments for a rare skin disease.

Via Investor's Business Daily

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 12, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 11, 2023

Via Benzinga

MoonLake Immunotherapeutics to host a Capital Markets Day on Monday, September 11

September 06, 2023

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 31, 2023

Via Benzinga

Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts ↗

August 31, 2023

Needham initiated coverage on MoonLake Immunotherapeutics (NASDAQ: MLTX) with a Buy rating and

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2023 ↗

August 31, 2023

Via Benzinga

The 7 Most Promising Momentum Stocks to Own Now ↗

August 31, 2023

These momentum stock picks are on a run, but it isn't too late to ride the rollercoaster amid broad market volatility.

Via InvestorPlace

MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update

August 10, 2023

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic arthritis (PsA) and provides calendar of next readouts

July 25, 2023

From MoonLake Immunotherapeutics AG

Via GlobeNewswire

10 Short Squeeze Stocks To Watch: Baosheng Media, Toro Corp, Getty Images And More ↗

July 18, 2023

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among...

Via Benzinga

Price Target For MoonLake Doubled: Analyst Says Lead Program Has 'Best-In-Class Profile' ↗

July 17, 2023

HC Wainwright has increased the price target for MoonLake Immunotherapeutics (NASDAQ: MLTX) from $37 to $75

Via Benzinga

Ford Motor Cuts Prices For F-150 Lightning Truck, Microsoft-Sony Sign Agreement for 'Call of Duty,' Alibaba Stock Slips on China's Q2 GDP Sentiment: Today's Top Stories ↗

July 17, 2023

Benzinga

Via Benzinga

MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022 ↗

July 17, 2023

MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for...

Via Benzinga

10 Short Squeeze Stocks To Watch: Asset Entities, Lightning eMotors, Bullfrog AI, Carvana And More ↗

July 10, 2023

Via Benzinga

$40M Bet On MoonLake Immunotherapeutics? Check Out These 3 Stocks Insiders Are Buying ↗

July 06, 2023

Although US stocks closed lower on Wednesday, there were a few notable insider trades.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 04, 2023

Via Benzinga

10 Short Squeeze Stocks To Watch: A Leader That Moved Up 392 Positions, Intuitive Machines, Toro And More ↗

July 03, 2023

Via Benzinga

MarketBeat Week in Review – 6/26 - 6/30

July 01, 2023

Markets headed into a holiday week cheering a lower-than-expected key inflation reading, but investors should expect volatility in a short trading week.

Via MarketBeat

Topics Economy

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com